IE43778L - Solid solutions of ergot alkaloids in polymers - Google Patents
Solid solutions of ergot alkaloids in polymersInfo
- Publication number
- IE43778L IE43778L IE762282A IE228276A IE43778L IE 43778 L IE43778 L IE 43778L IE 762282 A IE762282 A IE 762282A IE 228276 A IE228276 A IE 228276A IE 43778 L IE43778 L IE 43778L
- Authority
- IE
- Ireland
- Prior art keywords
- polymers
- solid solutions
- ergot alkaloids
- preparation
- solid material
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to a process for the preparation of a solid material composed of ergot peptide alkaloids, their hydrogenated forms or their salts and polyvinylpyrrolidone. The solid material obtained according to the invention can be used for the preparation of pharmaceutical compositions.
[GB1560406A]
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2546577A DE2546577B2 (en) | 1975-10-17 | 1975-10-17 | Solid substances made from polyvinylpyrrolidone and ergot alkaloids |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE43778L true IE43778L (en) | 1977-04-17 |
| IE43778B1 IE43778B1 (en) | 1981-05-20 |
Family
ID=5959411
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE2282/76A IE43778B1 (en) | 1975-10-17 | 1976-10-15 | Solid solutions of ergot alkaloids in polymers |
Country Status (28)
| Country | Link |
|---|---|
| JP (1) | JPS5854122B2 (en) |
| AT (1) | AT362510B (en) |
| AU (1) | AU508628B2 (en) |
| BE (1) | BE847368A (en) |
| CA (1) | CA1079641A (en) |
| CH (1) | CH643737A5 (en) |
| CS (1) | CS199647B2 (en) |
| DE (1) | DE2546577B2 (en) |
| DK (1) | DK146194C (en) |
| ES (1) | ES452420A1 (en) |
| FI (1) | FI762875A (en) |
| FR (1) | FR2327764A1 (en) |
| GB (1) | GB1560406A (en) |
| GR (1) | GR61268B (en) |
| HK (1) | HK3183A (en) |
| HU (1) | HU172533B (en) |
| IE (1) | IE43778B1 (en) |
| IL (1) | IL50686A (en) |
| MY (1) | MY8400063A (en) |
| NL (1) | NL184558C (en) |
| NO (1) | NO144468C (en) |
| NZ (1) | NZ182341A (en) |
| PH (1) | PH14513A (en) |
| PT (1) | PT65719B (en) |
| SE (1) | SE430379B (en) |
| SG (1) | SG63082G (en) |
| SU (1) | SU1165223A3 (en) |
| ZA (1) | ZA766166B (en) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1572226A (en) * | 1977-11-03 | 1980-07-30 | Hoechst Uk Ltd | Pharmaceutical preparations in solid unit dosage form |
| US4411882A (en) | 1978-12-21 | 1983-10-25 | Sandoz Ltd. | Galenical compositions |
| CH642259A5 (en) * | 1978-12-21 | 1984-04-13 | Sandoz Ag | GALENIC PREPARATIONS FOR ORAL APPLICATION OF ERGOTAL CALOIDS. |
| FR2454804B1 (en) * | 1979-04-26 | 1986-11-21 | Sanofi Sa | DIHYDROERGOTOXIN-BASED MEDICINAL PRODUCT AND PROCESS FOR PREPARING THE SAME |
| US4366145A (en) * | 1981-06-24 | 1982-12-28 | Sandoz, Inc. | Soft gelatin capsule with a liquid ergot alkaloid center fill solution and method of preparation |
| US4898729A (en) * | 1983-12-09 | 1990-02-06 | Euroceltique, S.A. | Treatment of hypertension, compounds and compositions for antihypertension and diuresis |
| HU198844B (en) * | 1984-06-14 | 1989-12-28 | Sandoz Ag | Process for producing new galenic pharmaceutical composition ensuring retarded release of active ingredient |
| ES2039287T3 (en) * | 1987-01-14 | 1993-09-16 | Ciba-Geigy Ag | PROCEDURE FOR OBTAINING A PERORAL THERAPEUTIC SYSTEM FOR HARDLY SOLUBLE ACTIVE PRODUCTS. |
| FR2610827B1 (en) * | 1987-02-18 | 1991-09-13 | Pf Medicament | DIHYDROERGOTAMINE (D.H.E.) TABLET OF THE HYDROPHILIC MATRIX TYPE AND MANUFACTURING METHOD THEREOF |
| US5064656A (en) * | 1989-11-14 | 1991-11-12 | Dr. Gergely & Co. | Uncoated pharmaceutical reaction tablet |
| DE4401646A1 (en) * | 1994-01-21 | 1995-07-27 | Krewel Werke Gmbh | Optimally releasing kava extracts |
| US6524832B1 (en) | 1994-02-04 | 2003-02-25 | Arch Development Corporation | DNA damaging agents in combination with tyrosine kinase inhibitors |
| US6632455B2 (en) | 1997-12-22 | 2003-10-14 | Schering Corporation | Molecular dispersion composition with enhanced bioavailability |
| CN1116039C (en) * | 1997-12-22 | 2003-07-30 | 先灵公司 | Molecular dispersion composition with enhanced bioavailability |
| US6316462B1 (en) | 1999-04-09 | 2001-11-13 | Schering Corporation | Methods of inducing cancer cell death and tumor regression |
| US7771746B2 (en) | 1999-12-03 | 2010-08-10 | Polichem Sa | Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
| EP1235574B1 (en) * | 1999-12-03 | 2005-02-02 | Polichem S.A. | Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
| US7135436B2 (en) | 2003-05-05 | 2006-11-14 | J.F. Daley International, Ltd. | Solid algicide, preparation and usage in recirculating water |
| EP1638527B1 (en) * | 2003-06-27 | 2006-10-25 | BIOPROGRESS S.p.A. | Composite product obtainable by cogrinding of an active principle with a copolymer n-vinyl-2-pyrrolidone/vinyl-acetate |
| JP6796083B2 (en) | 2015-06-09 | 2020-12-02 | カプスゲル・ベルギウム・ナムローゼ・フェンノートシャップＣａｐｓｕｇｅｌ Ｂｅｌｇｉｕｍ ＮＶ | Formulation to achieve rapid dissolution of drug in capsules from spray-dried dispersion |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1175430A (en) * | 1966-04-07 | 1969-12-23 | Sandoz Ltd | Pharmaceutical Compositions containing Ergot Alkaloids |
-
1975
- 1975-10-17 DE DE2546577A patent/DE2546577B2/en not_active Withdrawn
-
1976
- 1976-10-01 CH CH1244876A patent/CH643737A5/en not_active IP Right Cessation
- 1976-10-08 FI FI762875A patent/FI762875A/fi not_active Application Discontinuation
- 1976-10-08 DK DK454176A patent/DK146194C/en not_active IP Right Cessation
- 1976-10-08 NO NO763446A patent/NO144468C/en unknown
- 1976-10-08 SE SE7611189A patent/SE430379B/en not_active IP Right Cessation
- 1976-10-13 NL NLAANVRAGE7611295,A patent/NL184558C/en not_active IP Right Cessation
- 1976-10-14 CA CA263,423A patent/CA1079641A/en not_active Expired
- 1976-10-14 FR FR7630866A patent/FR2327764A1/en active Granted
- 1976-10-14 PH PH19008A patent/PH14513A/en unknown
- 1976-10-15 CS CS766685A patent/CS199647B2/en unknown
- 1976-10-15 NZ NZ182341A patent/NZ182341A/en unknown
- 1976-10-15 BE BE171578A patent/BE847368A/en not_active IP Right Cessation
- 1976-10-15 AT AT767976A patent/AT362510B/en not_active IP Right Cessation
- 1976-10-15 ZA ZA00766166A patent/ZA766166B/en unknown
- 1976-10-15 SU SU762412401A patent/SU1165223A3/en active
- 1976-10-15 HU HU76SA00002985A patent/HU172533B/en not_active IP Right Cessation
- 1976-10-15 PT PT65719A patent/PT65719B/en unknown
- 1976-10-15 GB GB42907/76A patent/GB1560406A/en not_active Expired
- 1976-10-15 IL IL50686A patent/IL50686A/en unknown
- 1976-10-15 ES ES452420A patent/ES452420A1/en not_active Expired
- 1976-10-15 AU AU18754/76A patent/AU508628B2/en not_active Expired
- 1976-10-15 IE IE2282/76A patent/IE43778B1/en not_active IP Right Cessation
- 1976-10-16 JP JP51123463A patent/JPS5854122B2/en not_active Expired
- 1976-10-16 GR GR51952A patent/GR61268B/en unknown
-
1982
- 1982-12-23 SG SG630/82A patent/SG63082G/en unknown
-
1983
- 1983-01-20 HK HK31/83A patent/HK3183A/en unknown
-
1984
- 1984-12-30 MY MY63/84A patent/MY8400063A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IE43778L (en) | Solid solutions of ergot alkaloids in polymers | |
| AU504675B2 (en) | Partially hydrogenated block copolymer composition | |
| IL49411A0 (en) | Phenylalkane-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
| NZ179835A (en) | Aminoalkynoic acids,derivatives and pharmaceutical compositions | |
| IL50932A (en) | Carbo(hetero)bicyclic ethanolamine derivatives,process for their preparation and pharmaceutical compositions containing them | |
| IL50618A0 (en) | Clavulanic acid amines,their preparation and pharmaceutical compositions containing them | |
| IL50690A0 (en) | Novel benzisothiazole derivatives,their preparation and pharmaceutical compositions containing them | |
| HU177823B (en) | Rodenticide composition containing n-alkyl-2,4-dinitro-6-trifluoromethyl-diphenyl-amine derivatives and process for producing the active agents | |
| PH13173A (en) | Derivatives of 5-alkoxy-3-phenyl-1,3,4-oxadiazolin-2-one composition and their method of preparation | |
| IL50736A0 (en) | Phenoxyalkylcarboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
| DE2861461D1 (en) | Derivatives of aminobenzoic acids, process for their preparation and pharmaceutical compositions containing them. | |
| CS194774B2 (en) | Process for preparing derivatives of 1,4-dihydropyridine suitable especially as antihypertensive and antianginar medicament | |
| GB1537871A (en) | Serum albumin polymers serum albumin compositions and methods for their preparation | |
| IL49668A (en) | Stable solutions of hydrogenated ergopeptide alkaloids,their preparation and pharmaceutical composition comprising them | |
| JPS5217434A (en) | Novel compound*process for preparation thereof and pharmaceutical composition | |
| AU505379B2 (en) | Naphthyl derivatives, processes for their preparation and pharmaceutical compositions containing them | |
| IE43849L (en) | Omega-thienyloxy-prostaglandins. | |
| IL61222A0 (en) | Ergot peptide alkaloids, their production and pharmaceutical compositions containing them | |
| ZA763955B (en) | 1,4-dihydropyridine derivatives process for preparation thereof and pharmaceutical composition of the same | |
| CA1027561A (en) | Pharmacologically active 1,4-benzodiazepins and process for their preparation | |
| GB1520179A (en) | Aminobenzoic acid derivatives process for preparing the same and pharmaceutical composition containing the same | |
| IL48888A0 (en) | Imidazolobenzodiazepines,processes for their preparation and compositions incorporating them | |
| PH12173A (en) | Benzodiazepines-2-one derivatives,pharmaceutical composition and method of use thereof | |
| AU493473B2 (en) | 3-amino-indazolecarboxylic acid derivatives, process for their preparation and their use as medicaments | |
| IL49442A (en) | (3-carboxy-2-methyl-5-indolyloxy)alkanoic acid derivatives,process for their preparation and pharmaceutical compositions comprising them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Patent lapsed |